Are you effectively linking cognitive tools with biomarkers for accurate Alzheimer&#x27;s disease (AD) diagnosis?<br>Credit available for this activity expires: 06/25/2027<br>Earn Credit / Learning Objectives &amp; Disclosures: https://www.medscape.org/viewarticle/case-based-discussion-linking-cognitive-testing-biomarker-2026a1000law?ecd=bdc_podcast_libsyn_mscpedu

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer's Disease

Keeping Current CME

Prior to beginning the activity, please be sure to review the faculty information and disclosure statements, as well as the learning objectives. After listening to the activity, complete the post-test by clicking the Earn Credit link in the episode description. Downloadable slides and resources are also available. The following presentation is copyrighted by Medscape.

No use, broadcast, or recording of this presentation, or any part thereof, is permitted without the written authorization of Medscape. The following presentation is part of a certified educational activity provided by Medscape Education and supported by an independent educational grant from Lilly. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities.

However, trade and manufacturer names in this activity are provided in an effort to provide clarity. The use of brand or manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer. Hello, I'm Dr. Sharon Cohen, neurologist and medical director at Toronto Memory Program in Toronto, Canada.

Welcome to this case-based discussion on linking cognitive testing with biomarker testing in Alzheimer's disease. Joining me today are Dr. Gregory Jaica, who is a professor of neurology at the Sanders-Brown Center on Aging at the University of Kentucky, and Michelle Milkey, who is chair and professor in the Department of Epidemiology and Prevention at the Wake Forest University School of Medicine. Welcome to you both.

During the next half hour or so, we'll discuss how to combine cognitive and biomarker testing in establishing a diagnosis of Alzheimer's disease, using cases to help illustrate points. First, Greg, can you give us an overview of the current guidance on diagnosing Alzheimer's disease? Sure, Sharon, I would love to.

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer's Disease

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer's Disease

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.